Understanding the barriers and attitudes toward influenza vaccine uptake in the adult general population: a rapid review
VL Welch, T Metcalf, R Macey, K Markus, AJ Sears… - Vaccines, 2023 - mdpi.com
Influenza is a common respiratory infection associated with a substantial clinical, humanistic,
and economic burden globally. Vaccines are essential to prevent and control influenza and …
and economic burden globally. Vaccines are essential to prevent and control influenza and …
[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023
M Kobayashi - MMWR. Recommendations and Reports, 2023 - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
Drivers of and barriers to routine adult vaccination: A systematic literature review
We performed a systematic literature review in PubMed and Embase (2016–2021) to
investigate the drivers of and barriers to routine vaccination in adults aged 50 and older …
investigate the drivers of and barriers to routine vaccination in adults aged 50 and older …
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults≥ 65 years of age with different prior …
K Cannon, C Elder, M Young, DA Scott, IL Scully… - Vaccine, 2021 - Elsevier
Introduction A 20-valent pneumococcal conjugate vaccine, PCV20, was developed to
expand protection against vaccine-preventable pneumococcal disease. PCV20 contains the …
expand protection against vaccine-preventable pneumococcal disease. PCV20 contains the …
Age and location in severity of COVID‐19 pathology: Do lactoferrin and pneumococcal vaccination explain low infant mortality and regional differences?
R Root‐Bernstein - BioEssays, 2020 - Wiley Online Library
Two conundrums puzzle COVID‐19 investigators: 1) morbidity and mortality is rare among
infants and young children and 2) rates of morbidity and mortality exhibit large variances …
infants and young children and 2) rates of morbidity and mortality exhibit large variances …
County-level predictors of coronavirus disease 2019 (COVID-19) cases and deaths in the United States: what happened, and where do we go from here?
JM McLaughlin, F Khan, S Pugh… - Clinical Infectious …, 2021 - academic.oup.com
Abstract Background The United States has been heavily impacted by the coronavirus
disease 2019 (COVID-19) pandemic. Understanding microlevel patterns in US rates of …
disease 2019 (COVID-19) pandemic. Understanding microlevel patterns in US rates of …
Effectiveness of 13-valent pneumococcal conjugate vaccine against medically attended lower respiratory tract infection and pneumonia among older adults
Background Among older adults, 13-valent pneumococcal conjugate vaccine (PCV13) has
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …
Association of pneumococcal conjugate vaccine use with hospitalized pneumonia in Medicare beneficiaries 65 years or older with and without medical conditions …
M Kobayashi, MW Spiller, X Wu, R Wang… - JAMA Internal …, 2023 - jamanetwork.com
Importance The association of 13-valent pneumococcal conjugate vaccine (PCV13) use with
pneumonia hospitalization in older adults, especially those with underlying medical …
pneumonia hospitalization in older adults, especially those with underlying medical …
Exposure, susceptibility, and recovery: a framework for examining the intersection of the social and physical environments and infectious disease risk
Despite well-documented evidence that structurally disadvantaged populations are
disproportionately affected by infectious diseases, our understanding of the pathways that …
disproportionately affected by infectious diseases, our understanding of the pathways that …
A narrative review of HPV vaccination interventions in rural US communities
HM Brandt, RC Vanderpool, M Pilar, M Zubizarreta… - Preventive …, 2021 - Elsevier
Uptake of human papillomavirus (HPV) vaccine in the United States (US) is far below the
Healthy People 2020 goal of 80% coverage among adolescents. In rural communities, HPV …
Healthy People 2020 goal of 80% coverage among adolescents. In rural communities, HPV …